We are an immunotherapy-focused biotech company pursuing the development of novel therapies to improve clinical outcomes in patients with cancer and other diseases with an unmet clinical need. Based on reverse translational science and emerging disease biology, we leverage the power of innate immunity and Treg cells as we believe these areas offer tremendous potential for developing innovative and effective therapies -- breaking new ground in the biotech industry.
MORE